{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T05:40:45Z","timestamp":1761716445788},"reference-count":25,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2004,11,1]],"date-time":"2004-11-01T00:00:00Z","timestamp":1099267200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Urology"],"published-print":{"date-parts":[[2004,11]]},"DOI":"10.1016\/j.eururo.2004.06.020","type":"journal-article","created":{"date-parts":[[2004,7,22]],"date-time":"2004-07-22T19:46:18Z","timestamp":1090525578000},"page":"647-650","source":"Crossref","is-referenced-by-count":13,"title":["In Vitro Activity of Fluoroquinolones, Azithromycin and Doxycycline against Chlamydia Trachomatis Cultured from Men with Chronic Lower Urinary Tract Symptoms"],"prefix":"10.1016","volume":"46","author":[{"given":"V.","family":"Smelov","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Perekalina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Gorelov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Smelova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Artemenko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Norman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.eururo.2004.06.020_bib1","unstructured":"Naber KG, Bergman B, Bishop MC, Bjerklund-Johansen TE, Botto H, Lobel B, Jinenez Cruz F, Selvaggi FP. Prostatitis, epididymitis and orchitis. In: EAU guidelines on urinary and male genital tract infection. Arhnem: Drukkerij Gelderland BV; 2001."},{"issue":"6","key":"10.1016\/j.eururo.2004.06.020_bib2","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1159\/000019784","article-title":"The role of antibiotics in the treatment of chronic prostatitis: a consensus statement","volume":"34","author":"Bjerklund Johansen","year":"1998","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2004.06.020_bib3","unstructured":"Centers for Disease Control. Sexually Transmitted Diseases Treatment Guidelines. 2002;51(RR-6):32\u20136."},{"issue":"5A","key":"10.1016\/j.eururo.2004.06.020_bib4","first-page":"S22","article-title":"Chronic prostatitis: current concepts and antimicrobial therapy","volume":"13","author":"Nickel","year":"2000","journal-title":"Infect Urol"},{"issue":"Suppl A","key":"10.1016\/j.eururo.2004.06.020_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/25.suppl_A.1","article-title":"In-vitro activity of azithromycin, erythromycin, ciprofloxacin and norfloxacin against Neisseria gonorrhoeae, Haemophilus ducreyi, and Chlamydia trachomatis","volume":"25","author":"Slaney","year":"1990","journal-title":"J Antimicrob Chemother."},{"issue":"4","key":"10.1016\/j.eururo.2004.06.020_bib6","first-page":"313","article-title":"In vitro evaluation of activities of azithromycin, clarithromycin and sparfloxacin against Chlamydia trachomatis","volume":"41","author":"Lefevre","year":"1993","journal-title":"Pathol Biol (Paris)"},{"issue":"3","key":"10.1016\/j.eururo.2004.06.020_bib7","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1128\/AAC.39.3.760","article-title":"Susceptibilities of Chlamydia trachomatis isolates causing uncomplicated female genital tract infections and pelvic inflammatory disease","volume":"39","author":"Rice","year":"1995","journal-title":"Antimicrob Agents Chemother."},{"issue":"4","key":"10.1016\/j.eururo.2004.06.020_bib8","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1159\/000007192","article-title":"Minimum inhibitory and minimal lethal concentration against Chlamydia trachomatis dependent on the time of addition and the duration of the presence of antibiotics","volume":"45","author":"Notomi","year":"1999","journal-title":"Chemotherapy"},{"issue":"3","key":"10.1016\/j.eururo.2004.06.020_bib9","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0732-8893(01)00221-8","article-title":"In vitro susceptibility of recent clinical isolates of Chlamydia trachomatis to macrolides and tetracyclines","volume":"39","author":"Samra","year":"2001","journal-title":"Diagn Microbiol Infect Dis."},{"issue":"3","key":"10.1016\/j.eururo.2004.06.020_bib10","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/jac\/dkf145","article-title":"Comparative in vitro activity of garenoxacin against Chlamydia spp","volume":"50","author":"Donati","year":"2002","journal-title":"J Antimicrob Chemother."},{"issue":"10","key":"10.1016\/j.eururo.2004.06.020_bib11","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1128\/AAC.42.10.2474","article-title":"Sequencing of gyrase and topoisomerase IV quinolone-resistance-determining regions of Chlamydia trachomatis and characterization of quinolone-resistant mutants obtained in vitro","volume":"42","author":"Dessus-Babus","year":"1998","journal-title":"Antimicrob Agents Chemother."},{"issue":"12","key":"10.1016\/j.eururo.2004.06.020_bib12","doi-asserted-by":"crossref","first-page":"3288","DOI":"10.1128\/AAC.44.12.3288-3297.2000","article-title":"Persistence of Chlamydia trachomatis is induced by ciprofloxacin and ofloxacin in vitro","volume":"44","author":"Dreses-Werringloer","year":"2000","journal-title":"Antimicrob Agents Chemother."},{"issue":"5","key":"10.1016\/j.eururo.2004.06.020_bib13","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1093\/jac\/dkf031","article-title":"Serial passage of Chlamydia spp. in sub-inhibitory fluoroquinolone concentrations","volume":"49","author":"Morrissey","year":"2002","journal-title":"J Antimicrob Chemother."},{"key":"10.1016\/j.eururo.2004.06.020_bib14","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ijantimicag.2003.09.001","article-title":"Azithromycin treatment follow-up: antibacterial susceptibility of Chlamydia trachomatis in patients with chronic prostatitis.","volume":"23S1","author":"Smelov","year":"2004","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.eururo.2004.06.020_bib15","doi-asserted-by":"crossref","unstructured":"Nickel JC. Prostatitis: Evolving management strategies. In: Carson CC, editor, The urologic clinics of North America. Philadelphia: W.B. Saunders Company; 1999.","DOI":"10.1016\/S0094-0143(05)70215-9"},{"issue":"6","key":"10.1016\/j.eururo.2004.06.020_bib16","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1093\/infdis\/162.6.1309","article-title":"Partial characterization of Chlamydia trachomatis isolates resistant to multiple antibiotics","volume":"162","author":"Jones","year":"1990","journal-title":"J Infect Dis."},{"issue":"7","key":"10.1016\/j.eururo.2004.06.020_bib17","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1097\/00007435-199808000-00005","article-title":"Comparative in vitro susceptibility of a tetracycline-resistant Chlamydia trachomatis strain isolated in Toulouse (France)","volume":"25","author":"Lefevre","year":"1998","journal-title":"Sex Transm Dis."},{"issue":"4","key":"10.1016\/j.eururo.2004.06.020_bib18","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1086\/315372","article-title":"Multiple drug-resistant Chlamydia trachomatis associated with clinical treatment failure","volume":"181","author":"Somani","year":"2000","journal-title":"J Infect Dis."},{"key":"10.1016\/j.eururo.2004.06.020_bib19","series-title":"Sexually transmitted diseases","first-page":"407","article-title":"Chlamydia trachomatis infections of the adult.","author":"Stamm","year":"1999"},{"issue":"11","key":"10.1016\/j.eururo.2004.06.020_bib20","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.1128\/AAC.45.11.3001-3008.2001","article-title":"Effects of azithromycin and rifampin on Chlamydia trachomatis infection in vitro","volume":"45","author":"Dreses-Werringloer","year":"2001","journal-title":"Antimicrob Agents Chemother."},{"key":"10.1016\/j.eururo.2004.06.020_bib21","series-title":"Chlamydia infections: Proceedings of the Ninth International Symposium on Human Infection","first-page":"35","article-title":"Factors affecting chlamydial persistence or recurrence one and three months after treatment.","author":"Katz","year":"1998"},{"issue":"6","key":"10.1016\/j.eururo.2004.06.020_bib22","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1128\/AAC.43.6.1491","article-title":"Effect of azithromycin plus rifampicine versus that of azithromycin alone on the eradication of Chlamydia pneumoniae from lung tissue in experimental pneumonitis","volume":"43","author":"Wolf","year":"1999","journal-title":"Antimicrob Agents Chemother."},{"issue":"11","key":"10.1016\/j.eururo.2004.06.020_bib23","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.1128\/AAC.45.11.3001-3008.2001","article-title":"Effects of azithromycin and rifampin on Chlamydia trachomatis infection in vitro","volume":"45","author":"Dreses-Werringloer","year":"2001","journal-title":"Antimicrob Agents Chemother."},{"issue":"2","key":"10.1016\/j.eururo.2004.06.020_bib24","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s00345-003-0333-4","article-title":"Prostatitis: the role of antibiotic treatment","volume":"21","author":"Wagenlehner","year":"2003","journal-title":"World J Urol."},{"issue":"3","key":"10.1016\/j.eururo.2004.06.020_bib25","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0090-4295(03)00565-X","article-title":"Levofloxacin versus ciprofloxacin in the treatment of chronic bacterial prostatitis: a randomized double-blind multicenter study","volume":"62","author":"Bundrick","year":"2003","journal-title":"Urology."}],"container-title":["European Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283804003392?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283804003392?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,2]],"date-time":"2020-04-02T20:48:32Z","timestamp":1585860512000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0302283804003392"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,11]]},"references-count":25,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2004,11]]}},"alternative-id":["S0302283804003392"],"URL":"https:\/\/doi.org\/10.1016\/j.eururo.2004.06.020","relation":{},"ISSN":["0302-2838"],"issn-type":[{"value":"0302-2838","type":"print"}],"subject":[],"published":{"date-parts":[[2004,11]]}}}